146 related articles for article (PubMed ID: 35790975)
1. GRB10 is a novel oncogene associated with cell proliferation and prognosis in glioma.
Chen Y; Tang M; Xiong J; Gao Q; Cao W; Huang J
Cancer Cell Int; 2022 Jul; 22(1):223. PubMed ID: 35790975
[TBL] [Abstract][Full Text] [Related]
2. CPLX2 is a novel tumor suppressor and improves the prognosis in glioma.
Chen Y; Ning J; Shu L; Wen L; Yan B; Wang Z; Hu J; Zhou X; Tao Y; Xia X; Huang J
J Neurooncol; 2024 Mar; 167(1):63-74. PubMed ID: 38427133
[TBL] [Abstract][Full Text] [Related]
3. Effects of
Chen Y; Tang M; Li H; Huang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):499-507. PubMed ID: 37385612
[TBL] [Abstract][Full Text] [Related]
4. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
[TBL] [Abstract][Full Text] [Related]
5. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
6. Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Liu Z; Shen F; Wang H; Li A; Wang J; Du L; Liu B; Zhang B; Lian X; Pang B; Liu L; Gao Y
Cell Cycle; 2020 Jul; 19(13):1632-1640. PubMed ID: 32436804
[TBL] [Abstract][Full Text] [Related]
7. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma.
Wang H; Liu Z; Li A; Wang J; Liu J; Liu B; Lian X; Zhang B; Pang B; Liu L; Gao Y
Exp Ther Med; 2021 Nov; 22(5):1224. PubMed ID: 34539820
[TBL] [Abstract][Full Text] [Related]
8. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
9. The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients.
Yao J; Chen X; Liu Z; Zhang R; Zhang C; Yang Q; Yao P; Jiang Q; Wu J; Zhao S
Chin Neurosurg J; 2021 Mar; 7(1):21. PubMed ID: 33750478
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of
Wang J; Liu Z; Zhang C; Wang H; Li A; Liu B; Lian X; Ren Z; Zhang W; Wang Y; Zhang B; Pang B; Gao Y
PeerJ; 2021; 9():e10820. PubMed ID: 33614284
[TBL] [Abstract][Full Text] [Related]
11. TRAF3IP3 promotes glioma progression through the ERK signaling pathway.
Lin Q; Chen Z; Shen ZL; Xue F; Qin JJ; Kang XP; Chen ZR; Xia ZY; Gao L; Chen XZ
Front Oncol; 2022; 12():776834. PubMed ID: 36185204
[TBL] [Abstract][Full Text] [Related]
12. SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity
Huang Q; Lian C; Dong Y; Zeng H; Liu B; Xu N; He Z; Guo H
Front Oncol; 2021; 11():698835. PubMed ID: 34490096
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
Front Oncol; 2021; 11():682932. PubMed ID: 34123852
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
15. NCAPG as a Novel Prognostic Biomarker in Glioma.
Jiang X; Shi Y; Chen X; Xu H; Liu B; Zhou F; Huang X; Cho WC; Li L; Pu J
Front Oncol; 2022; 12():831438. PubMed ID: 35280743
[TBL] [Abstract][Full Text] [Related]
16. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Xia L; Jin P; Tian W; Liang S; Tan L; Li B
Braz J Med Biol Res; 2021; 54(7):e10236. PubMed ID: 34008750
[TBL] [Abstract][Full Text] [Related]
18. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
19. CUX1 Facilitates the Development of Oncogenic Properties
Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
[No Abstract] [Full Text] [Related]
20. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
